Pharmaceutical

MilliporeSigma opens two new mRNA manufacturing facilities in Germany

MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany.

Sep 27, 2023 - 20:00
MilliporeSigma opens two new mRNA manufacturing facilities in Germany
MilliporeSigma has opened two new messenger ribonucleic acid (mRNA) drug substance manufacturing facilities in Germany.
Read the original article

Tags:

Previous Article

Arcturus Therapeutics extends cystic fibrosis treatment deal

Next Article

Alfasigma to buy Intercept Pharmaceuticals for $794m

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Oramed Pharmaceuticals sees highest patent filings and grants during April in Q2 2024

Oramed Pharmaceuticals sees highest patent filings and ...

Jul 22, 2024

UNAIDS boss calls on Gilead to provide ‘miracle’ drug to developing countries

UNAIDS boss calls on Gilead to provide ‘miracle’ drug t...

Jul 24, 2024

Fighting AMR with a value and subscription model 

Fighting AMR with a value and subscription model 

Jul 17, 2023